
Copper Peptide · Investigational
The Science of Skin Renewal
Discover the Copper Peptide Behind Emerging Skin and Tissue Research
GHK-Cu is a naturally occurring copper-binding tripeptide studied for its potential roles in collagen-related processes, skin remodeling, cellular signaling, and tissue repair. Although early research is promising in certain laboratory and topical contexts, injectable GHK-Cu remains investigational. Its safety and effectiveness for skin rejuvenation, hair growth, anti-aging, or systemic wellness have not been established in humans.
GHK-Cu injectable is not FDA-approved. Its safety and effectiveness have not been established, and it is not currently available for ordering.
Investigational — not available for ordering until pharmacy availability and regulatory eligibility are confirmed.

The Copper Peptide
GHK-Cu is a copper-binding peptide studied for its possible involvement in skin and tissue biology — including research into collagen, skin remodeling, cellular signaling, and tissue repair. Laboratory findings and topical-skincare studies do not establish the safety or effectiveness of injected GHK-Cu. Its safety, dosing, effectiveness, and long-term outcomes for cosmetic or wellness use have not been established in humans.
Injectable GHK-Cu has not been established as safe or effective for skin rejuvenation, hair growth, anti-aging, or systemic wellness. The FDA has identified safety concerns involving compounded injectable GHK-Cu, including potential immunogenicity and peptide-related impurities. Compounded formulations are not FDA-approved and have not been reviewed by the FDA for safety, effectiveness, or quality before marketing. This page is educational and not medical advice.
GHK-Cu injection is not an FDA-approved treatment. Its safety and effectiveness for cosmetic or wellness purposes — including skin rejuvenation, hair growth, anti-aging, or systemic wellness — have not been established in humans. Human clinical evidence is limited, and safety, dosing, effectiveness, and long-term outcomes have not been established. The FDA has identified safety concerns involving compounded injectable GHK-Cu, including potential immunogenicity and peptide-related impurities. Compounded medications are not FDA-approved and have not been reviewed by the FDA for safety, effectiveness, or quality before marketing. Laboratory findings and topical-skincare studies do not establish the safety or effectiveness of injected GHK-Cu. This page is educational, does not promise whole-body rejuvenation, improved immunity, accelerated recovery, or anti-aging benefits, and is not medical advice. Always discuss your full medical history with a licensed provider. This treatment is not available for ordering or checkout.